Results 81 to 90 of about 16,929 (203)

Validation and use of microdialysis for determination of pharmacokinetic properties of the chemotherapeutic agent mitomycin C - an experimental study [PDF]

, 2010
Background Mitomycin C is a chemotherapeutic agent used in the treatment of peritoneal surface malignancies, administered as hyperthermic intraperitoneal chemotherapy after cytoreductive surgery. Pharmacokinetic studies have been based on
Olaf Sørensen, Anders Andersen, Harald Olsen, Kristian Alexandr, Per Olaf Ekstrøm, Karl-Erik Giercksky, Kjersti Flatmark   +6 more
core   +2 more sources

The Ultrasonography Characteristics of Borderline Ovarian Tumor Subtypes

Journal of Ultrasound in Medicine, Volume 44, Issue 11, Page 2133-2146, November 2025.
Roni Yoeli‐Bik, Ernst Lengyel, Ilan E. Timor‐Tritsch, Katherine Kurnit, Serghei Puiu, Ryan E. Longman, Jacques S. Abramowicz   +6 more
wiley   +1 more source

Circulating tryptophan–kynurenine pathway metabolites are associated with all‐cause mortality among patients with stage I–III colorectal cancer

International Journal of Cancer, Volume 156, Issue 3, Page 552-565, 1 February 2025.
What's new? Tryptophan is catabolized by the kynurenine pathway, which generates several different metabolites. Improper activation of this pathway may play a role in colorectal cancer (CRC). Here, the authors show for the first time that in CRC patients, an increased kynurenine‐to‐tryptophan ratio prior to surgery is associated with an increased risk ...
Victoria Damerell, Niels Klaassen‐Dekker, Stefanie Brezina, Jennifer Ose, Arve Ulvik, Eline H. van Roekel, Andreana N. Holowatyj, Andreas Baierl, Jürgen Böhm, Martijn J. L. Bours, Hermann Brenner, Johannes H. W. de Wilt, William M. Grady, Nina Habermann, Michael Hoffmeister, Pekka Keski‐Rahkonen, Tengda Lin, Peter Schirmacher, Petra Schrotz‐King, Alexis B. Ulrich, Fränzel J. B. van Duijnhoven, Christy A. Warby, David Shibata, Adetunji T. Toriola, Jane C. Figueiredo, Erin M. Siegel, Christopher I. Li, Andrea Gsur, Ellen Kampman, Martin Schneider, Per M. Ueland, Matty P. Weijenberg, Cornelia M. Ulrich, Dieuwertje E. Kok, Biljana Gigic, FOCUS Consortium   +35 more
wiley   +1 more source

Pseudomyxoma peritonei originating from appendix tumors

Journal of Coloproctology, 2018
Background: Appendix tumors represent about 1% of all gastrointestinal neoplasia, in other words they are quite rare. However, there is a specific type of appendiceal neoplasms (mucinous adenocarcinoma) that spreads to the peritoneum and in almost 20% of
Tatiana Maria Fernandes Moreira Marques, Laura Elisabete Ribeiro Barbosa   +1 more
doaj   +1 more source

Undetermined Ruptured Low‐Grade Appendiceal Mucinous Neoplasm Following High‐Energy Blunt Abdominal Trauma Requiring Emergency Laparotomy

Clinical Case Reports, Volume 13, Issue 1, January 2025.
ABSTRACT Blunt abdominal trauma causing intraperitoneal injury and/or bleeding can be life‐threatening, requiring immediate intervention. Diagnosing these cases can be challenging, especially when pre‐existing conditions are involved. Low‐grade appendiceal mucinous neoplasm (LAMN) is a rare tumor of the appendix that can lead to pseudomyxoma peritonei.
Ippei Matsuo, Tetsuya Yumoto, Akari Tsuji, Ryo Tanabe, Toshihisa Matsumura, Mikoto Shimabara, Masaaki Akai, Shoji Takagi, Hiromichi Naito, Atsunori Nakao   +9 more
wiley   +1 more source

Stemness and hybrid epithelial‐mesenchymal profiles guide peritoneal dissemination of malignant mesothelioma and pseudomyxoma peritonei

International Journal of Cancer, Volume 156, Issue 1, Page 201-215, 1 January 2025.
What's new? Factors involved in peritoneal dissemination of malignant mesothelioma (MM) and pseudomyxoma peritonei (PMP) are poorly characterized. Increased amounts of cancer stem cells identified high‐grade PMP and distinguished mass‐derived from ascitic/mucin‐associated cells in MM and PMP.
Nayana Lazzari, Giulia Rigotto, Barbara Montini, Paola Del Bianco, Elena Moretto, Federica Palladino, Rocco Cappellesso, Marco Tonello, Carola Cenzi, Antonio Scapinello, Maria Assunta Piano, Carlo Riccardo Rossi, Piero Dalerba, Pierluigi Pilati, Antonio Sommariva, Maria Luisa Calabrò   +15 more
wiley   +1 more source

Pseudomyxoma peritonei

Medicina Clínica, 2023
Nathaniel Juárez de la Garza, Joaquín Juárez-Durán, Irma E. Gómez-Rodríguez, Gerardo Rivera-Silva   +3 more
openaire   +4 more sources

Pseudomyxoma Peritonei: Radiological Aspect

International Journal of Anatomy Radiology and Surgery, 2018
Pseudomyxoma peritonei is one of the complications of mucin secreting tumours arising from appendix or ovary. Malignancy of biliary tree, urachus and colon may also have similar presentation.
Ashish Garg, Nivedita Sharma, Rahul Khetawat, Neeraj Wadhwa, Nishu Ra   +4 more
doaj   +1 more source

Bases and foundations of the treatment of peritoneal carcinomatosis: Review article [PDF]

, 2016
Peritoneal carcinomatosis refers to a shedding or tumor that spreads to the peritoneal serosa and structures of the abdominal cavity. It is an entity with a poor prognosis.
Barrios Sánchez, P., Castro Mesta, Julio Fernando, González Guerrero, Juan Francisco, Villarreal Cavazos, Gerardo   +3 more
core  

Cytoreductive surgery plus hyperthermic intraperitoneal chemotherapy for patients with peritoneal metastases from endometrial cancer [PDF]

, 2017
Background: More information is needed for selection of patients with peritoneal metastases from endometrial cancer (EC) to undergo cytoreductive surgery (CRS) plus hyperthermic intraperitoneal chemotherapy (HIPEC). Methods: This study analyzed clinical,
Biacchi, Daniele, Christopoulou, Athina, Ciardi, Antonio, Cornali, Tommaso, Efstathiou, Elias, Framarino dei Malatesta, Marialuisa, Kopanakis, Nikolaos, Sammartino, Paolo, Spagnoli, Alessandra, Spiliotis, John   +9 more
core   +1 more source